| AbbVie AG - Rinvoq 30 mg, Retardtabletten | | 67257 | | 05 | | Rinvoq 30 mg | | Retardtabletten | | | | | | 07.06.2024 | | |
| | Composition | | upadacitinibum 30 mg ut upadacitinibum hemihydricum, cellulosum microcristallinum, hypromellosum, mannitolum, acidum tartaricum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Upadacitinibum | 30 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Upadacitinibum | 30 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Acide Tartarique | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Mannitol | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 28 | 765.24 | 848.65 | B | LS | Non |
|
|
